KROS

Keros Therapeutics, Inc.

NasdaqGM · Healthcare

$11.65

+5.62% today

last filing 2026-06-11Pro sees filings in ~15 min

Price

hover · 4 moves explained

1 buy13 sells45 8-K

Analyst consensus

$21.83target+87.4%vs $11.65 today

$16.00 low today target$30.00 high

6 analysts · ~12-month consensus · as of Jul 8. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 2 of last 4

Earnings per share · actual vs forecast

Q2 '25+32.5%

−$0.76

exp −$1.13

Q3 '25+80.5%

−$0.18

exp −$0.92

Q4 '25-90.4%

−$0.86

exp −$0.45

Q1 '26-31.5%

−$1.21

exp −$0.92

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-06-15	Newton Charles W.	Director	—Direct	550	$10.04	$5.5K
Sell	2026-06-05	Seth Alpna	Director	—Direct	2,625	$10.72	$28.1K
Grant	2026-06-05	GRAY MARY ANN	Director	—Direct	7,142	—	—
Grant	2026-06-05	Farzan Nima	Director	—Direct	7,142	—	—
Grant	2026-06-05	BIENAIME JEAN JACQUES	Director	—Direct	7,142	—	—

Sell

Newton Charles W.

Director · 2026-06-15

$5.5K

550 @ $10.04

Sell

Seth Alpna

Director · 2026-06-05

$28.1K

2,625 @ $10.72

Grant

GRAY MARY ANN

Director · 2026-06-05

—

7,142 shares

Grant

Farzan Nima

Director · 2026-06-05

—

7,142 shares

Grant

BIENAIME JEAN JACQUES

Director · 2026-06-05

—

7,142 shares

30 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →